Department Introduction

Neurology | Our Speciality

:::

Our Speciality

China Medical University Hospital | Department of Neurology

Neurology Specialized Services

Parkinson Disease & MRgFUS | Alzheimer’s Disease

Neurologist assessing a patient in the MRgFUS treatment room

Precision Treatment of Parkinson Disease with MR-guided Focused Ultrasound and Innovative Translational Research on Targeted Exosomes, PAA Peptide, and Neural-Targeted Mitochondrial Transplantation

00 Core Expertise

We integrate AI-assisted assessment, digital twin modeling, and neuroimaging to support precision diagnosis and personalized treatment of Parkinson disease, including MRI-guided focused ultrasound (MRgFUS), while connecting multidisciplinary care with translational research into disease mechanisms and novel therapies.

00 Key Features

1. Integrated care

Our center brings together specialists in neurology, neurosurgery, neuroradiology, rehabilitation medicine, nuclear medicine, artificial intelligence, and genetics. Treatment planning considers disease stage, functional priorities, cognitive status, and comorbidities, with rehabilitation and other supportive services tailored to each patient’s needs.

Our distinctive stepwise dual-target approach

MRI-guided focused ultrasound (MRgFUS) delivers focused ultrasound energy through the intact skull to create a precisely targeted thermal lesion without a cranial incision or implanted stimulation hardware. Treatment is generally performed while the patient is awake, with MRI guidance, real-time temperature monitoring, and repeated neurological examinations to assess symptom response and potential adverse effects.

Our team’s distinctive stepwise approach targets cardinal features including tremor, rigidity and bradykinesia [1–3].

2. Collaboration with exosome and mitochondrial research teams to advance the following areas

(1) Innovative applications of specifically targeted exosomes in Alzheimer’s disease

We investigate specifically targeted exosomes as an innovative research approach, exploring their potential for precision delivery and neuroprotection to advance the development and translation of emerging therapeutic strategies for Alzheimer’s disease.

(2) Research on PAA peptide as an innovative therapeutic approach for Alzheimer’s disease

We explore the therapeutic potential of PAA peptide in Alzheimer’s disease. Through mechanistic studies and efficacy evaluation, we assess its feasibility as a novel therapeutic strategy.

(3) Research on neural-targeted mitochondrial transplantation as an innovative therapeutic approach

We investigate neural-targeted mitochondrial transplantation to explore its potential to improve cellular energy metabolism and support neuronal function, thereby establishing a translational research foundation for precision treatment of Alzheimer’s disease.

iEV-102
iEV-102 delivers BDNF mRNA through engineered extracellular vesicles, showing potential to promote neurite outgrowth and improve memory-related behavior in preclinical models as a novel therapeutic strategy for Alzheimer’s disease.
Photo (to be provided)

00 Clinical Outcomes

Our published cohort, treated-side MDS-UPDRS Part III motor scores, encompassing tremor, rigidity, and bradykinesia, improved by approximately 72% at 12 months when assessed off medication. This result reflects improvement in the assessed treated-side motor items. [2]
Patient-reported outcomes also indicated benefit, with 79% reporting improvement on the Clinical Global Impression (CGI) assessment.
Our Parkinson disease and tremor care team has received the National Healthcare Quality Award (NHQA) Gold Award and the Symbol of National Quality (SNQ) certification.

00 Selected Research Publications

00 International Accreditations and Awards

  • 2025, 2026: Best Specialized Hospitals Asia Pacific – Neurology 2026 (Newsweek).
  • 2023 National Healthcare Quality Award (NHQA) Gold Award
  • 2022 The Symbol of National Quality (SNQ) certification.
  • 2025: Invited Speaker in Madrid, Spain
  • 2026: Invited Speaker in Milan, Italy
  • 2026: Invited Speaker at the Taiwan Neurological Society
  • 2026: Invited Speaker in Hong Kong

00 Medical Team and Patient Access

Consultation hotline: 04-22052121, extensions 12003

Assessment for novel therapies: Eligibility requires diagnostic and biomarker confirmation, together with counseling regarding treatment efficacy, risks, and follow-up requirements.

Appointments: Book a Neurology outpatient visit through our online appointment system.

Precision Treatment of Alzheimer’s Disease and Innovative Translational Research on Targeted Exosomes, PAA Peptide, and Neural-Targeted Mitochondrial Transplantation

00 Core Expertise

We integrate cognitive assessment, biomarkers, and neuroimaging to provide precision diagnosis and treatment for early-stage dementia, including anti-amyloid therapy, while linking multidisciplinary care with innovative translational research in neurodegenerative diseases.

00 Key Features

1. Integrated care

Our center brings together specialists in neurology, psychiatry, rehabilitation medicine, family medicine, nuclear medicine, and diagnostic imaging. By integrating psychological assessment, biomarkers, and amyloid positron emission tomography (PET), we provide diagnostic services, assessment for novel therapies, and treatment monitoring.

2. Collaboration with exosome and mitochondrial research teams to advance the following areas

(1) Innovative applications of specifically targeted exosomes in Alzheimer’s disease

We investigate specifically targeted exosomes as an innovative research approach, exploring their potential for precision delivery and neuroprotection to advance the development and translation of emerging therapeutic strategies for Alzheimer’s disease.

(2) Research on PAA peptide as an innovative therapeutic approach for Alzheimer’s disease

We explore the therapeutic potential of PAA peptide in Alzheimer’s disease. Through mechanistic studies and efficacy evaluation, we assess its feasibility as a novel therapeutic strategy.

(3) Research on neural-targeted mitochondrial transplantation as an innovative therapeutic approach

We investigate neural-targeted mitochondrial transplantation to explore its potential to improve cellular energy metabolism and support neuronal function, thereby establishing a translational research foundation for precision treatment of Alzheimer’s disease.

Neuro-Targeted Mitochondrial Transplantation
Neuro-targeted mitochondrial transplantation is a preclinical strategy aimed at restoring energy and synaptic function in damaged neurons, with the potential to reduce Alzheimer’s pathology and improve memory.
PAA peptide
This figure illustrates the preclinical potential of PAA peptide to target abnormal proteins and promote their autophagic clearance, aiming to preserve mitochondrial, cognitive, and motor function.
Integrated Platform for New Drug Development
Integrated Platform for New Drug Development
Photo (to be provided)

00 Clinical Outcomes

Publicly reported milestone: The hospital’s first patient received donanemab treatment on October 21, 2025.
Number of patients and treatment encounters for novel therapies: 19 patients.
Cumulative repetitive transcranial magnetic stimulation (rTMS) treatment sessions: 458.

00 International Accreditations and Awards

  • 2026: Best Specialized Hospitals Asia Pacific – Neurology 2026 (Newsweek).

00 Medical Team and Patient Access

Team: Interprofessional collaboration includes neurology, psychiatry, rehabilitation medicine, family medicine, nuclear medicine, radiology, psychologists, and social workers. Refer to the team profiles on the official website for the physician roster.

Appointments: Select the Dementia Clinic through the hospital’s online appointment system. Patients should bring previous examination results and medication records for specialist assessment and arrangement of any necessary investigations.

Consultation hotline: 04-22052121, extensions 17465 and 17466.

Assessment for novel therapies: Eligibility requires diagnostic and biomarker confirmation, together with counseling regarding treatment efficacy, risks, and follow-up requirements.

Appointments: Book a Neurology outpatient visit through our online appointment system.

Stay connected with CMUH
How to get to CMUH the map of hospital
▲